The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Campaigns & Insights
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / October / Purely Refractive IOL Demonstrates Good Results in Eyes with Ocular Comorbidities
Anterior Segment Refractive News

Purely Refractive IOL Demonstrates Good Results in Eyes with Ocular Comorbidities

Real-world data on Tecnis PureSee IOLs presented at ESCRS London

10/6/2026 2 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll

Clinical Report: Purely Refractive IOL Demonstrates Good Results in Eyes with Ocular Comorbidities

Overview

A retrospective analysis of 418 patients with ocular comorbidities showed that those implanted with bilateral Tecnis PureSee IOLs achieved excellent distance and good intermediate vision, along with functional near vision.

Background

The management of patients with ocular comorbidities seeking refractive lens exchange (RLE) poses unique challenges in achieving optimal visual outcomes. Understanding the performance of intraocular lenses (IOLs) in this patient population is crucial for improving visual quality and patient satisfaction. The Tecnis PureSee IOL, with its non-diffractive design, aims to balance visual acuity and minimize dysphotopsia.

Data Highlights

Visual AcuityDistance (logMAR)Intermediate (logMAR)Near (logMAR)
Mean Uncorrected Binocular Visual Acuity-0.0020.1310.224
Proportion of Patients (≥0.20 logMAR)95.7%78.0%45.5%

Key Findings

  • Patients achieved a mean uncorrected binocular visual acuity of -0.002 logMAR at distance.
  • At two months post-RLE, 95.7% of patients had a distance visual acuity of 0.20 logMAR or better.
  • Near vision was most affected in patients with macular disease, with 45.5% achieving 0.20 logMAR or better.
  • The PureSee IOL's non-diffractive design preserves contrast sensitivity and reduces the incidence of bothersome halos.
  • A mild monovision strategy can enhance functional near vision while maintaining good distance and intermediate performance.

Clinical Implications

Clinicians should provide thorough counseling to patients with ocular comorbidities regarding realistic expectations for visual outcomes post-RLE.

Conclusion

The Tecnis PureSee IOL demonstrates good visual outcomes while addressing the challenges of spectacle independence.

Related Resources & Content

  1. Ophthalmology Management, 2025 -- Purely Refractive EDOF IOL Reduces Spectacle Dependence
  2. Ophthalmology Management, 2021 -- How to utilize premium IOLs
  3. Corneal Physician, 2022 -- Selecting an IOL
  4. ScienceDirect -- Recommendation for Presbyopia-Correcting Intraocular Lenses: A Delphi Consensus Statement by the ESASO Study Group
  5. Johnson & Johnson, 2026 -- Clinical Data for TECNIS PureSee IOL
  6. The Ophthalmologist, 2026 -- Purely Refractive IOL Demonstrates Good Results in Eyes with Ocular Comorbidities
  7. Ophthalmology Management — IOL psychology
  8. Recommendation for Presbyopia-Correcting Intraocular Lenses: A Delphi Consensus Statement by the ESASO Study Group - ScienceDirect
  9. Johnson & Johnson Showcases New Clinical Data for TECNIS PureSee IOL at ASCRS 2026 Demonstrating Excellent Contrast Sensitivity and Extended Range of Vision | J&J MedTech US
  10. The Ophthalmologist | Purely Refractive IOL Demonstrates Good Results in Eyes with Ocular Comorbidities

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: